People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Maxwell Biosciences, Inc. | — | Biotechnology | Series B | $35.9M | $270.0M | 2021 |
| Celestial Therapeutics Inc. | — | Biotechnology | Seed | $2.1M | $3.5M | 2024 |
Annelise Barron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Annelise Barron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Praveen Tyle | 1 | 5 |
| GEORGE SIBER | 1 | 3 |
| Theodore Moskovitz | 1 | 2 |
| ANNELISE E BARRON | 1 | 1 |
| LEONTIS E TERYAZOS | 1 | 1 |
| JOHN E FORTKORT | 1 | 1 |
| Joshua McClure | 1 | 1 |
| Kate McKinley | 1 | 1 |
| Barbara R Holcomb | 1 | 1 |
| Christopher Johns | 1 | 1 |
| Leontis Teryazos | 1 | 1 |
| Ajay Gupta | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.